Motor Neurone Disease Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- Adults who have been diagnosed with a neurodegenerative condition, such as mild cognitive impairment (MCI), Parkinson's disease, Alzheimer's disease, ALS, multiple sclerosis, Huntington's disease, traumatic brain injury, concussion, PTSD, Down Syndrome, or similar conditions
- Adults who do not have a neurodegenerative condition (healthy volunteers may also be eligible)
Who may not be able to join:
- People who are unable to cooperate with or complete the testing, or who have eye or vision conditions related to age or other neurological causes that could affect the quality of eye images taken during the study
- People who have had eye surgery inside the eye itself, except for cataract surgery (having had cataract surgery is acceptable)
A note about eye eligibility:
- If both of your eyes meet the study requirements, both may be included; if only one eye qualifies, just that eye will be included in the study
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Sharon Fekrat, MD FACS FASRS, Duke University
Phone: 919-681-3937
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Change in ganglion cell-inner plexiform layer (GCIPL) thickness; Change in retinal nerve fiber layer (RNFL) thickness; Change in central subfield thickness (CST); Change in choroidal vascularity index (CVI); Change in foveal avascular zone (FAZ) area; Change in average perfusion density (PD); Change in average vessel density (VD); Change in average capillary perfusion density (CPD); Change in average capillary flux index (CFI)
Can't join this trial?
Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.